The clinical spectrum of herpes simplex virus (HSV) infections, ranging from asymptomatic to frequently distressing outbreaks, suggests that there may be immunologic determinants of disease severity that are associated with human leukocyte antigen (HLA) expression. A controlled, prospective study identified several major histocompatibility complex (MHC) class I and II antigens whose frequencies are associated with HSV-2 infection or with frequent symptomatic genital recurrences. Previous studies were hampered by the inability to serologically identify patients with asymptomatic HSV-2 infection. Clinical evaluation and Western blot assay were used to identify 3 subject cohorts: 1 with no prior HSV infections, 1 with HSV-2 antibodies but no recognized symptoms, and 1 with HSV-2 antibodies and frequent genital recurrences. Statistical comparisons of HLA frequencies among these cohorts showed associations of HLA-B27 and -Cw2 with symptomatic disease. Also, HLA-Cw4 was significantly associated with HSV-2 infection. These associations indicate that immunologic factors linked to the MHC influence the risk of HSV-2 infection and disease expression.
Clinicians have long appreciated the pleiotropic manifestations of genital herpes. Symptomatic herpes simplex virus type 2 (HSV-2) infections present as frequent and painful recurrences in some persons, while others recognize only a single primary outbreak without subsequent recurrences or only rare recurrences [1] [2] [3] . Recently, another subset of HSV-2-infected patients has been delineated and well characterized: those with no recognized primary illness or recurrences but with subclinical or totally asymptomatic infection and reactivation [4] [5] [6] . Both groups of infected individuals shed virus and transmit it to intimate partners and neonates [7] [8] [9] .
The development of type-specific serologic assays has now permitted the reliable identification of asymptomatically in-fected people [10] . The ability to accurately define both the symptomatic and asymptomatic ends of the spectrum of HSV-2 infections provides new opportunities to study host factors that could determine the extent to which people will recognize and suffer herpetic recurrences.
One host mechanism that could contribute to the overall response to and clinical expression of HSV-2 infection is the human major histocompatibility complex (MHC), which comprises the loci of genes, including the human leukocyte antigens (HLAs) [11] . HLA-A, -B, and -Cw genes constitute the family of MHC class I antigens, which present endogenously derived foreign peptides to CD8 ϩ cytotoxic T lymphocytes (CTL). MHC class II antigens include HLA-DR and -DQ, which present exogenously derived foreign peptides to CD4 ϩ T helper lymphocytes.
The extreme polymorphism of MHC molecules, most predominant in their peptide binding clefts, is credited with a portion of individual variability in intrinsic immunity. Individual HLAs and the peptides they present influence the vigor with which a response is mounted and, in some instances, whether that response will be directed against self antigens. Thus, HLA determinants can be, and in many instances have been, associated with disease severity and spectrum [12, 13] . HLA-B27 has perhaps the most infamous of disease associations, being strongly linked to the eventual development of spondyloar- NOTE. Data in parentheses are % of subjects. Symptomatic and asymptomatic subjects were seropositive for HSV-2 and seronegative or seropositive for HSV-1; uninfected subjects were seronegative for both HSV-1 and -2.
thropathies and acute anterior uveitis [14] . The haplotype HLA-A1, -B8, -DR3 is associated with heightened susceptibility to dermatitis herpetiformis and autoimmune hepatitis [15] and, recently, with increased risk for human immunodeficiency virus (HIV) disease [16] .
As with other targets of host defenses, innate antiviral immune mechanisms rely on MHC class I and class II peptide presentation, suggesting that allelic polymorphisms contribute to individual variability in antiviral immunity. A number of studies have addressed this question with regard to HSV infections [17] [18] [19] [20] ; however, difficulty in identifying the appropriate uninfected control participants has until now confounded their interpretation. That is, in the absence of type-specific serologic tests, the failure to recognize and accurately diagnose certain individuals (i.e., those who are infected with one or the other HSV type yet remain asymptomatic) diluted groups of truly uninfected controls by their presence. Moreover, there could be no reliable comparison of HLA frequencies among the important groups of symptomatically and asymptomatically infected persons.
We present here the HLA typing results of 3 carefully defined patient populations representing (1) individuals experiencing six or more symptomatic genital HSV-2 recurrences per year (when untreated), (2) individuals who are truly uninfected (HSV-1-and HSV-2-seronegative), and (3) those who have serologic evidence of HSV-2 infection but no symptomatic disease despite evaluation and counseling as to its usual features. The associations we found extend our current understanding of host responses to and the immunopathogenesis of HSV-2 disease.
Materials and Methods
Study population. Otherwise healthy study participants (n ϭ ) were selected from larger pools of persons being evaluated at 146 three centers for their suitability for vaccine or antiviral drug studies. Screening for these studies necessitated HSV type-specific serologic testing by Western blot [10] . The results occasionally identified HSV-2-seropositive persons who had no history of symptoms consistent with genital herpes and who, after receiving instructions regarding the usual spectrum of symptoms and signs, still claimed no previous symptoms.
We initially sought 150 subjects: 50 with serologically and clinically confirmed genital HSV-2 infection that was reported to recur six or more times per year prior to suppressive antiviral treatment, 50 HSV-2-seropositive yet asymptomatic individuals; and 50 who were seronegative for both HSV-1 and HSV-2. During enrollment and screening at three study sites, 162 subjects underwent HLA determination. Sixteen study participants, who were Asian, Hispanic, or African-American, were excluded from analysis because there were not sufficient numbers of racially matched control subjects.
HLA results of 146 white subjects were analyzed: 47 were seropositive for HSV-2 with or without HSV-1 and had frequent, clinically documented symptomatic genital recurrences; 44 subjects were seropositive for HSV-2 with or without HSV-1 and had asymptomatic infection; and 55 were seronegative for HSV-1 and HSV-2.
Typing methods. Four unrefrigerated 10-mL tubes with each subject's blood in acid citrate dextrose were shipped overnight to the University of California in Los Angeles for HLA typing. Lymphocytes were isolated, and CD4 ϩ and CD8 ϩ T cells were purified by positive selection, using immunomagnetic beads [21, 22] . Class I (HLA-A, -B, -Cw) typing was done by use of serologic methods [21] , and class II (HLA-DQ, -DR) typing was done by use of polymerase chain reaction [23, 24] . All data were tabulated according to clinical and serologic study group for statistical analysis.
Statistical methods. HLA data were analyzed to evaluate a possible association of alleles with HSV-2 infection or symptomatic disease. Gene frequencies were estimated from phenotypic data, under the Hardy-Weinberg law, using the maximum likelihood method [25, 26] . For comparing cases and controls in each of the specific alleles at each locus, individual x 2 and Fisher's exact tests were calculated [26, 27] . Bonferroni's correction for multiple comparisons was performed for the tests that showed significance [26, 28] . Fisher's exact test was also used for detecting a haplotype association with infection or disease [27] . All reported P values were two-tailed unless stated otherwise.
Results
Characteristics of the study population. Table 1 shows the characteristics of the study population with respect to sex, age, HSV serology, and HSV disease, and HLA group.
Gene frequencies of the 3 cohorts at the MHC class I and class II loci. Tables 2-6 show the gene frequencies of the study participants at the MHC class I loci HLA-A, -B, and -Cw and the class II loci HLA-DR and -DQ. HLA-A2, the most common of the HLA-A loci polymorphisms, was most prevalent in all 3 study cohorts. Greater allelic diversity is seen in the HLA-B loci, with HLA-B35 most frequent in HSV-infected participants and HLA-B7 most frequent in uninfected individ- Table 2 . Gene frequencies at the human leukocyte antigen A (HLA-A) locus for subjects in 3 study cohorts.
HLA-A allele
Symptomatic subjects (n ϭ 47)
Asymptomatic subjects (n ϭ 44) Uninfected subjects (n ϭ 55)
No. uals. At the HLA-Cw locus, HLA-Cw7 is most common in all cohorts. Among class II alleles, DR-13 is most frequently seen in participants with symptomatic HSV infection, and DR-4 is most frequent in individuals with asymptomatic HSV infection. In the uninfected population, both DR-13 and DR-4 are equally frequent isoforms. At the DQ loci, the DQ-2, -3, -5, and -6 isoforms are all prevalent.
Increased frequencies of individual genes in HSV-2-seropositive subjects. We compared the gene frequencies of the 91 HSV-2-infected symptomatic and asymptomatic subjects with those of the 55 HSV-seronegative subjects. The frequencies of several genes were significantly higher in HSV-2-seropositive subjects (table 7) .
An increase of allele A11 frequency is borderline significant ( ). Significant elevations of frequencies of alleles B35 P ϭ .05 ( ) and B38 ( ) were found in infected subjects. P ϭ .02 P ϭ .02 These three allelic frequencies were not significant when adjustments for multiple comparisons were made. None of the class II (DR and DQ loci) genes were associated with HSV-2 infection.
The number of HSV-2-infected subjects with the Cw4 antigen was 13-fold greater than that among uninfected controls ( vs. ; odds ratio, 4.22). As shown in 27/91 ϭ 0. 30 5/55 ϭ 0.09 table 7, the increased Cw4 frequency was highly significant ( ). Even with application of Bonferroni's correction P ϭ .003 for multiple comparisons, the difference between infected and uninfected subjects was still significant ( ). P ϭ .027 Differing gene frequencies among symptomatic and asymptomatic subjects with HSV-2 infection. Table 7 compares the estimated individual gene frequencies that had statistically significant differences between cohorts of symptomatically and asymptomatically infected subjects. HLA-A1, -DR13, and -DQ6 are positively associated with having frequent symptomatic recurrences of genital herpes. HLA-A32, -B27, and -Cw2, however, are negatively associated with symptomatic disease. Given the many alleles studied, particularly at the A and B loci, one may say that some comparisons would appear significant by chance. With statistical correction for multiple comparisons, however, the comparisons involving B27 and Cw2 still yielded strong trends toward significance ( and P ϭ .08 , respectively). P ϭ .06
Frequencies of individual haplotypes in the study cohorts. The "autoimmune" haplotype, A1, B8, and DR3, occurred in 5 (10.6%) of 47 symptomatic patients, 2 (4.5%) of 44 asymptomatic patients, and 9 (16.4%) of 55 uninfected persons. Thus, the allelic frequency of these haplotypes in symptomatic persons was more than twice that in asymptomatic persons, but the difference did not achieve statistical significance. Moreover, the frequency (7.7%) of this haplotype among all 91 infected subjects was less than half that for uninfected subjects ( ). P ϭ .09 Of the 91 infected subjects, 24 (26.4%) had two antigens at different loci, B35 and Cw4, while 5 (9.1%) of 55 uninfected subjects had the two antigens at different loci. Fisher's exact test showed a significant association of the haplotype B35-Cw4 with infection ( ). P ϭ .01 The frequencies of the haplotype A11, B35 also showed interesting differences among the study cohorts. This haplotype was seen in 4 (8.5%) of 47 symptomatic patients and in 2 (4.5%) of 44 asymptomatic patients but in no uninfected subjects. A positive association of A11, B35 with HSV-2 infection is almost significant using a one-tailed exact test ( ). P ϭ .055 Table 3 . Gene frequencies at the human leukocyte antigen B (HLA-B) locus for subjects in 3 study cohorts.
HLA-B allele
Asymptomatic subjects (n ϭ 44) Uninfected subjects (n ϭ 55) 
Discussion
Herein, we report MHC class I and class II antigen frequencies that are associated with HSV-2 infection or with the likelihood that HSV infection will be manifested by frequent symptomatic recurrences. These observations are compatible with known associations between polymorphisms at HLA loci and responses to other microbial pathogens, and they implicate host immune factors as determinants of the risks of HSV-2 infection and disease.
Coexpression of HSV peptides in the context of MHC class I and class II antigens is required for CD8 ϩ T cell killing of infected cells and for CD4 ϩ T cell-mediated regulation of B cell responses to viral proteins, respectively [29] [30] [31] . All herpes viruses studied possess mechanisms for deterring these host responses by down-regulating the presentation of their antigens together with MHC proteins and by severely limiting their antigen expression during latency. Epstein-Barr virus nuclear antigen-1 (EBNA-1), for example, is the only protein required for viral persistence in B cells, and it contains a glycine-alanine repeat motif that blocks proteosomal degradation and antigen presentation [32] . Cytomegalovirus encodes 4 gene products that, together, block multiple steps in MHC presentation [33, 34] . HSV-1-and -2-infected cell protein 47 (ICP47) blocks peptide transport into the Golgi complex, where ICP47 would normally bind to class I a chains, while the gene 41 protein shuts off host cell protein synthesis, including the MHC proteins [35, 36] . Further, HSV-associated fetal loss may be due to impaired trophoblast expression of HLA-G, a nonclassical class I protein with significant homology to HLA-A and -B, and resultant NK cell-mediated cytotoxicity [37, 38] . Moreover, HSV-1 and -2 persist in neurons, which normally display no class I molecules, and while latent, these express only one family of transcripts, which are not known to encode proteins [39] . For much of their residence in humans, then, HSV-1 and -2 are essentially invisible to the immune system. Immune responses to HSV are engaged only during the typically brief periods in which the virus is replicating in peripheral tissues while en route to or from its neuronal sanctuary. The nature and efficiency of these responses determine the outcome of each episode of infection [40] .
The HLA isotype and the particular viral peptides that it binds are one set of factors that influence the outcome of a given herpesvirus infection. That the responsiveness of T cells from healthy seropositive individuals to HSV or cytomegalovirus glycoproteins B relates to the HLA haplotype provides Table 5 . Gene frequencies at the human leukocyte antigen DQ (HLA-DQ) locus for subjects in 3 study cohorts.
HLA-DQB1 allele
Symptomatic subjects (n ϭ 47) Asymptomatic subjects (n ϭ 44) Uninfected subjects (n ϭ 55) one indication that the MHC may modulate the pathogenesis of herpesvirus diseases [41, 42] . Moreover, particular MHC class I proteins determine which viral peptides can serve as targets for CTL killing. For example, EBNAs 3A, 3B, and 3C serve as CTL targets over a wide range of HLA backgrounds; however, responses to Epstein-Barr virus latent membrane protein 2 and EBNA 2 engage CTL with a limited number of HLA determinants [43] . Several epidemiologic studies addressed the clinical correlates of HLA alleles in HSV disease. Studies of a Sicilian population identified a negative correlation of HLA-B35 and a positive correlation of HLA-DR2 [17, 18] with HSV-1 infection, findings that were not confirmed for HSV-2 in our study. HLA associations with labial herpes infection in an Iraqi population showed significantly higher frequencies of HLA-A1, -B8, and -DR1 in the infected cohort; however, subgroup analyses found no associations with higher recurrence rates [19] . The high prevalence of HSV-1 infection worldwide, however, would imply that most of the HSV-1-negative controls in the Iraqi study were actually asymptomatic and not identifiable as such by the methods employed. If that is true, their higher frequency of A1 antigens would agree with the present data that distinguish symptomatic and asymptomatic persons with HSV-2 infection. The study of the Framingham cohort (1977) (1978) (1979) found a decreased frequency of HLA-Bw16 and an increased frequency of Cw2 in individuals with a history of herpes labialis [20] . In that study, however, 63% of the control population relating no history of cold sores had detectable HSV-1 titers compared with 93% of the cohort giving a positive history, verifying the unreliability of patient history as a marker of serologic status.
Correlations between selected HLA allelic isoforms and postherpetic erythema multiforme have also been described and illustrate the potential impact of HLA and disease expression in herpes simplex infections. HLA-B62 and -B35 were significantly more frequent in affected patients, while the autoimmune haplotype A1, B8, and DR3 appeared to be protective [44] . A variety of studies showed that MHC class II isoforms HLA-DR1, -DR4, and -DR53 occurred more frequently in erythema multiforme-affected individuals; however, none of the studies confirmed the findings of the other [44] [45] [46] [47] .
Thus, there are common inconsistencies among studies of HLA associations with HSV infection. Some of the inconsistencies may have arisen because of multiple comparisons among data obtained from small study cohorts-a potentially valid concern regarding the present data, although we did perform statistical corrections to accommodate the multiple comparisons. In all of the prior HSV studies, however, an equally, if not more, important factor affecting their validity was the inability to accurately define the serologic status and to verify the clinical presentation of the subjects. In the present study, we used the Western blot assay to verify serologic status [10] , and patients were documented clinically to have frequently recurring symptomatic genital herpes. A cohort of truly HSV-seronegative and, thus, uninfected subjects was established, and their HLA frequencies were compared with those of well-characterized HSV-2-infected cohorts. In so doing, we found several HLA loci to be associated with HSV-2 infection. Of these, the greatest proportional difference was with HLA-Cw4, which was detected in significantly more infected than uninfected subjects. Correlation of HLA-Cw4 with HSV infection may be due to inefficient or loss of appropriate triggering of the CTL response. Clearance of HSV-2 from genital lesions is associated with high-level CTL response [48] . The levels of HSV-specific CD8 ϩ CTL precursors are lower in HIVinfected patients who experience recurrent HSV-2 disease than in patients with mild HSV disease [49] . Further, HSV-1-infected cells are resistant to CTL-induced apoptosis [50] . Possibly, early and aggressive elimination of virally infected cells by CTL prevents HSV disease. That infection could be abrogated entirely is suggested by studies of HIV disease, in which innate immunity, as defined by chemokine receptor polymorphisms, does prevent HIV infection [51] . Proof that innate immunity could prevent HSV-2 infection would require detailed observations and daily cultures for virus shedding in well-characterized, serodiscordant couples.
HLA-B27 and HLA-Cw2 are associated with asymptomatic infection. In African-Americans, HLA-Cw2 is associated with an increased risk of developing multiple myeloma [52] , while HLA-B27 is a well recognized risk factor for spondyloarthropathies and acute anterior uveitis [14] . HLA-B27-linked spondyloarthropathies arise following certain bacterial genitourinary infections [14] . Similarly, male HLA-B27/human b 2 -microglobulin-transgenic mice develop spontaneous arthritis of the hind legs and nail changes when moved from sterile to conventional housing [53] . These mice are also susceptible to Listeria monocytogenes, developing severe inflammatory bowel disease and dying upon exposure [54] . Further, transfected human monocytic lines expressing HLA-B27 show impaired elimination of Salmonella enteritidis [55] .
The cumulative data argue that MHC-linked factors contribute to disease symptomatology, although the nexus of immune interactions with HSV may be too complex to propose straightforward and traditional associations between HLA allelic frequencies and clinical outcomes. While HLA-B27, which is often associated with autoimmunity, is correlated with asymptomatic genital herpes, the autoimmune haplotype, HLA-A1-B8-DR3, was observed twice as frequently in symptomatic than asymptomatic patients. Carriers of the B8-DR3 haplotype have a predominant Th2 profile [56] . Moreover, the HLA haplotype A1, B8, DR3 itself is a risk factor for HIVrelated disease [16] and progression to AIDS [57] . HLA haplotype B8-DR3 also confers susceptibility to autoimmunerelated hepatitis C virus mixed cryoglobulinemia [58] . This suggests that symptomatic infection has an immunopathologic component. Recent data on asymptomatic shedding are in accord with this possibility in that they demonstrate that fairly comparable quantities of infectious virus and viral DNA are recovered during symptomatic and asymptomatic outbreaks [59] . Thus, what appears to distinguish the episodes may be more the extent of host response-mediated injury than virusinflicted injury.
The importance of NK cell activity in response to herpesvirus infections is exemplified by a patient who completely lacked an NK cell population. The patient developed severe varicella, cytomegalovirus, and herpes simplex infections in succession [60] . NK cell-mediated cytotoxicity presents a first-line antimicrobial response and is limited by NK cell inhibitory receptor recognition of HLA peptides. Group 1 and group 2 NK cells recognize HLA-Cw alleles; however, HLA binding of exogenous peptides is required to mediate the inhibitory signal [61] [62] [63] . of interest, loading of specific coxsackievirus peptide sequences or the superantigen glutamic acid decarboxylase onto HLA-Cw7 abrogates the normal inhibitory response of NK cells and may be causal in the development of autoimmune diabetes melitis [64] . The apparent protective role of HLA-Cw2 in HSV symptomatic disease may underlie a more robust initial immune response by NK cells, resulting in a diminished population of latent virus. Conversely, HLA modulation of the NK response may portend the vigor of the immune response to HSV reactivation.
How and whether the MHC alleles are themselves responsible for defining the variable host responses to HSV is unclear. The MHC itself appears to regulate cytokine production [56] , presenting the possibility that elaborated cytokines may contribute to the risk of acquiring herpes infection and disease. Moreover, it is possible that other genes closely linked to and that cosegregate in populations with them are responsible [12, 65] . Various complement genes, tumor necrosis factor (TNF) genes, genes for peptide transporters, and the proteosome complex all map close to the MHC loci. In this regard, it is noteworthy that peptide transporter and TNF gene variants have been implicated in susceptibility to HIV and cerebral malaria (reviewed in [66] ).
The present study suggests that purification of HSV peptides that bind particular HLA motifs associated with protection against infection or disease would provide rational components of immunoprophylactic or immunotherapeutic vaccines for genital herpes [67] .
